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ABSTRACT 
In recent years the number of postmortem cases in which 
cocaine involvement is suspected has increased considerably. 
This has created a need for a rapid screening procedure for 
the postmortem samples. The present study examined the 
usefulness of vitreous humor specimens, analyzed by a rapid 
immunological assay, as a possible alternative to the more 
conventional and relatively slow gas chromatography/mass 
spectrometry of blood samples to screen for antemortem cocaine 
use. 
Medical examiner cases occurring over a six month period 
were reviewed and forty-ei~ht cases which were determined to 
be drug related or drug induced deaths were analyzed. Post-
mortem concentrations of cocaine and its hydrolysis product, 
benzoylecgonine, recovered from blood, were compared to the 
concentrations detected in vitreous humor. These specimens 
were screened via a rapid fluorescence polarization immuno-
assay (FPIA) and also analyzed by gas chromatography/ mass 
spectrometry (GC/MS) for a quantitation of cocaine and its 
primary hydrolysis product, benzoylecgonine. 
An assessment of FPIA to screen postmortem vitreous humor 
samples was carried out. The sensitivity of this method was 
0.03 mcg/ml. The vitreous humor cocaine metabolite levels by 
FPIA and GC/MS demonstrated a correlation coeificient of 0.7. 
Blood and vitreous humor benzoylecgonine levels from the same 
postmortem case analyzed by GC/MS showed a correlation coef-
ii 
ficient of o.s. 
Significant correlation of the FPIA results with the 
GC/MS results demonstrate that the FPIA analysis of vitreous 
humor samples appears to be a valid screening technique to 
detect antemortem cocaine use. The vitreous humor was found 
to be a clean and stable body fluid which was suitable for 
this technique. It is concluded that the screening of 
postmortem vitreous humor for cocaine use by this FPIA method 
is a useful and reliable screening technique in forensic 
toxicology. 
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1. 
I. INTRODUCTION 
Forensic toxicology is the study of poison isolation, 
identification, and quantitation from biological specimens for 
legal purposes. Most drug analyses in forensic toxicology are 
performed on urine, blood, or other tissue. During the multi-
step drug extraction processes, the samples are susceptible to 
emulsification and pipetting errors. Blood samples are also 
degraded by postmortem changes. The combination of all these 
factors may result in loss of sensitivity and poor reproduci-
bility in an assay. 
Another postmortem fluid which is readily available but 
is often ignored is vitreous humor. In comparison with blood 
and urine, it is not as susceptible to major postmortem 
changes. The vitreous is compartmentalized and isolated, 
which makes it a suitable toxicological material, even after 
embalming or putrefaction, when blood may be unavailable (Coe, 
and Sherman, 1970). 
This study investigated three main areas relating to 
fluorescence polarization immunoassay (FPIA) technology on 
vitreous humor specimens in determining drug use prior to 
death. First, the data generated was used to determine if 
elevated levels of cocaine and/or metabolites in blood are 
accompanied by elevated levels in vitreous humor. Secondly, 
this information coupled with the time between drug use and 
death (if available) might allow a calculation as to how 
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rapidly cocaine and/or metabolites diffuse into vitreous humor 
specimens (Jones and Pounder, 1987). And lastly, this 
research further demonstrated that FPIA screening of vitreous 
humor specimens is valid in forensic toxicology. 
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II. LITERATURE REVIEW 
Vitreous humor is the fluid material which fills the 
posterior cavity of the eye. It is present at a volume of 2 
to 2.5 milliliters in each eye (Logan and Stafford, 1989). 
The vitreous (hyaloid body) occupies about 80% of the volume 
of the ocular globe. It provides structural support and 
maintains intraocular pressure • 
Chemically, the vitreous humor is a mucopolysaccharide 
gel composed of hyaluronic acid and collagen, and it has a 
water content of between 98 and 99.7% (Table 1). This table 
shows the relative simplicity and stability of vitreous humor. 
Vitreous humor is a clean bilogical fluid containing less 
protein than urine, and it can be collected with ease. In the 
forensic domain, the primary use of vitreous humor to date has 
been to aid in the postmortem diagnosis of disease, the 
analysis of electrolyte composition and enzymatic activity to 
determine "time-since-death" determinations (Devgun and 
Dunbar, 1986). 
Vitreous is a partitioned fluid; but the amount of water 
movement is very high (T 1/2 = 10-15 minutes) • This tends to 
make one expect that drug levels might be expected to show 
good correlation with corresponding blood levels. This is 
true of ethanol determinations and vitreous humor samples 
which are often analyzed postmortem for alcohol concentration. 
The mean ratio of vitreous humor to blood ethanol concen-
tration is 1.17 (Caplan and Levine, 1990). 
4. 
Table 1. Comparison of the Composition of Three Postmortem 
Body Fluids 
Putrif ied Blood 
(pH 4-9) 
Urine 
(pH 4-9) 
Water (20-70%) Water (96-99.9%) 
Few cells+debris Glucose 
Lysate Protein 
Clots Ammonia 
Denatured clots Creatinine 
Bacterial debris Urea 
Denatured protein Uric acid 
Fat droplets Steroids 
Steroids Pigments 
Putrefactive base Amino Acids 
Protein microagglutinates 
Enzymes 
Vitreous Humor 
(pH 7-7.8) 
Water (98- 99.7%) 
Glucose 
Hyaluronic Acid 
Anions/cations 
Collagen 
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The use of vitreous humor for toxicological analysis was 
first published involving ethanol determinations (Sturner and 
Cournbis, 1966) . In this publication the vitreous humor 
ethanol levels were compared to blood ethanol levels, obtained 
simultaneously at autopsy. There have been various reports 
subsequent to this, verifying the usefulness and accuracy of 
this approach (Coe and Sherman, 1970, Felby and Olsen, 1969, 
Ziminski et.al., 1984). 
In the literature, various drug distributions studies do 
mention vitreous drug levels, but little is said about the 
relation of these levels to blood levels or their ultimate 
interpretation. A study on alcohol levels illustrated that 
when patients have long survival times, they reveal blood/ 
vitreous values approaching unity (Sturner and Garriot, 1975). 
There is speculation that the ratios reached at equilibrium 
depend on the drug's lipid solubility, plasma protein binding, 
and solubility in vitreous humor. 
The substances that have been studied include such drugs 
as barbiturates, meprobamate, salicylates, ethchlorvynol, 
digoxin, quinine, and lithium (Felby and Olsen, 1969). Other 
studies have also appeared that relate levels of such drugs as 
barbiturates, methadone and morphine in vitreous humor to 
other tissues and fluids (Ziminski et. al., 1984). Quantita-
tive postmortem determinations of vitreous drug levels have 
been reported rather sporadically in the literature. 
The physical properties of vitreous humor make it a very 
good sample material for initial drug screening in postmortem 
cases. Active transport of some compounds into the eye has 
been observed in some cases. This has been observed in some 
tests conducted on rabbit eyes with delta-9-tetrahydro-
cannabinol transport (Sorensen, 1971). Most compounds are 
believed to enter the eye through passive diffusion, a process 
limited by their lipophilicity and their charge at physio-
logical pH. 
There are many advantages to postmortem toxicological 
analysis of vitreous humor. In most cases, the specimen is 
easily obtainable at autopsy and obtainable without the neces-
sity of an autopsy. Vitreous humor is often the best or only 
sample available; especially in cases of severe burning, when 
the body has been embalmed, in cases of advanced decomposi-
tion, and in cases of severe trauma. Vitreous is a clear, 
serous specimen and it is easy to work with analytically. It 
is also found in an isolated anatomical position. In 
addition, the lack of any metabolic activity in the eye 
suggests that vitreous levels might give a more accurate 
indication of drug concentrations present in the body at the 
time of death. Therefore, in the absence of a valid blood 
specimen, the vitreous humor specimen may permit toxico-
logical interpretation. However, there must be a wealth of 
data available relating vitreous levels to blood levels before 
such interpretation would be possible. 
The pharmacokinetics of any drug deals with the study of 
the time course of the drug and its metabolites in the body 
following administration. Every drug is subject to the 
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pharmacokinetic variables of absorption, distribution, 
metabolism, and excretion. The determination of the drug 
plasma levels is highly individual and depends upon these 
variables . 
In the human body, the drug, cocaine, is rapidly 
metabolized (T 1/2 = o. 7 to 1. 5 hours) to ecgonine methyl 
ester, ecgonine and other fragments by serum cholinesterase 
and liver esterases (Baselt and Cravey, 1989). Cocaine is 
broken down to benzoylecgonine by chemical hydrolysis (Figure 
1). These processes probably continue postmortem in the 
blood, liver and in drawn blood "in vitro". Enzymatic 
breakdown can be inhibited by any number of enzyme inhibitors, 
including fluoride, organophosphate pesticides, physostigrnine, 
and heavy metals. Hydrolysis can also be slowed by refriger-
ation or freezing and by decreasing the pH of the sample below 
neutral. Refrigeration retards both processes, while freezing 
blood samples containing sodium fluoride can preserve the 
cocaine for extended periods of time. 
One would expect cocaine in the blood to hydrolyze 
extensively between the time of death and the time when the 
autopsy blood specimens are taken. If survival time from 
dosage exceeds 48 hours, it would most likely result in a 
negative result, based on the elimination kinetics of the 
principal cocaine metabolite, benzoylecgonine. The mean 
urinary elimination half-life of benzoylecgonine has been 
estimated to be 4.5 hours (range, 2.8 to 10.5 hours) (Ambre 
et. al., 1988). Elimination rates are dependent, in part, on 
rq.._ 
Fig. 1. Cocaine .Metabolism showing Fonnation of .Metabolites 
8. 
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dosage, as well as other factors. Ambre in 1985 devised a 
nomogram based on published kinetic studies. Assuming a 
urinary output of 1 ml/min, this nomogram would predict that 
at least 0.35 mg/Lor 0.35 mcg/ml of benzoylecgonine should be 
detectable in the urine for up to 48 hours following a lOOmg 
or greater dose. These and other studies suggest that little 
metabolite would be detectable in urine by a homogeneous 
enzyme immunoassay with a detection limit of 0.30 mcg/ml 
beyond 48 hours from the last cocaine dose of lOOmg. 
In one review of the cocaine literature, it was evident 
that death from cocaine is rapid and unpredictable (Smart and 
Anglin, 1987) . None of the papers examined were able to 
illustrate how to translate postmortem values into actual 
doses taken. Many of the authors state that following an 
overdose of cocaine, death is astonishingly rapid (Welti and 
Fishbain, 1985, Welti and Wright, 1979, Mittleman and Welti, 
1984). Thus, it may not yet be possible to state the lethal 
dose of cocaine with any degree of certainty. 
It has been suggested that brain tissue may be the better 
sample for cocaine determination rather than postmortem blood 
or liver tissue (Sphiehler and Reed, 1985). Cocaine is known 
to enter and leave the brain rapidly. Some researchers feel 
that there is an active transport of cocaine into the brain 
tissue, rather than a passive diffusion. At peak plasma 
concentrations, the brain cocaine concentration is just over 
four times the plasma or serum concentration. This 
brain/blood ratio is the most frequent median found for 
lO. 
cocaine in cocaine overdose fatalities. As blood cocaine 
concentrations fall slightly more rapidly than brain tissue 
concentrations, the brain/blood ratio increases. This 
increase reaches a peak of approximately 10 (range 8 to 12) 
between one and two hours after cocaine administration. These 
authors recommend brain tissue for cocaine determinations over 
postmortem blood or liver tissue. Brain is a better matrix 
than blood for cocaine analysis because the parent drug is 
more stable in the brain's lipid-rich environment. However, 
the technical difficulties in getting the tissue prepared for 
ana lysis may outweigh the accuracy of the brain tissue for 
cocaine concentration. 
The examination of three human brains in the study by 
Browne, illustrated that cocaine and benzoylecgonine appear to 
be distributed throughout the different regions of the organ 
(Browne et al., 1991). This was in agreement with the 
findings of an earlier study by Spiehler and Reed (Spiehler 
and Reed, 1985). The concentrations of cocaine found in the 
brain were generally four to eight times greater than that 
found in blood. The addition of this study to the archives 
further suggests that brain tissue is a better sample than 
either blood or liver for cocaine determinations. However, 
working with brain tissue is difficult, as stated earlier. 
The presence in the brain of large concentrations of fats and 
other endogenous materials, make use of this specimen 
difficult. This material necessitates the use of lengthy and 
laborious extraction procedures. 
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One paper in the literature demonstrated the usefulness 
of testing decomposed human remains for cocaine in all cases 
where the presence is suspected (Manhoff et. al., 1991). 
Cocaine is generally quite labile and has a plasma half-life 
of less than one hour. It is known that in vivo it is rapidly 
hydrolyzed by .enzymatic and nonenzymatic reactions. Despite 
this, it has been found that cocaine and its metabolites are 
frequently detectable in decomposed human remains. Cocaine 
has been detected even in advanced cases of decomposition and 
mummification. 
Recent data now suggests that blood cocaine concen-
trations change significantly during the interval between 
death and autopsy . The change appears to be dependent upon 
the site from which the blood is sampled. Cocaine concen-
trations in the heart, aorta, and femoral vein blood increase 
during the interval between death and autopsy, while the 
subclavian vein blood decreases (Hearn et. al., 1991). This 
study emphasizes the difficulty in attempting to estimate the 
perimortem concentration of cocaine in the blood from any 
postmortem data. The data implies that cocaine accumulates in 
some tissues, such as the brain and the liver, and these 
demonstrate higher cocaine concentrations than in the blood. 
In another study where the two eyes were sampled at 
different postmortem intervals, markedly different cocaine 
levels were demonstrated (Beno and Kriewall, 1989). In this 
study also, postmortem release is the only reasonable 
explanation for this unusual finding. In a case study of 
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cocaine involved in a fatal poisoning, cocaine tissue 
concentrations and body fluid concentrations were reported in 
the literature for this case (Pokl±s et. al., 1985). The 
blood level of cocaine was 1. 8 mcg/ml and vitreous humor 
level was 2.4 mcg/ml. 
for the parent drug 
The blood/vitreous ratio in this case 
cocaine was 0.75. There was no 
benzoylecgonine levels reported in this case report as the 
procedure used did not analyze for benzoylecgonine. The 
survival time was known to be less than 2 hours and the drug 
was intravenously administered. 
The incidence of cocaine abuse has arisen dramatically 
over recent years. This has directly resulted in a major 
increase in deaths attributed to cocaine overdose as well as 
to increased findings of cocaine during the screening of 
biological samples for drugs of abuse. There are numerous 
methods in the literature describing the analysis of cocaine 
and its hydrolysis product, benzoylecgonine in body fluids, 
using high performance liquid chromatography (HPLC) and gas 
chromatography/mass spectrometry (GC/MS) (Chinn et. al., 1980, 
Evans and Morarity, 1980, Griesmer et. al~, 1983, Logan and 
Stafford, 1989, Tebbett and McCartney, 1988). All of these 
methods require that the drugs be first extracted from the 
biological matrix prior to chromatographic analysis. 
Extraction of cocaine and benzoylecgonine is generally by 
liquid-liquid extraction procedures. Liquid-liquid extraction 
normally involves the use of volumes of solvents, numerous 
centrifugation, back extraction and evaporation steps before 
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the sample is suitable for analysis. Such methods can provide 
clean extracts with good recoveries, however the method is 
time consuming, often requiring several hours to extract a 
single sample. In addition, emulsion formation with some 
organic solvents may hinder phase separation, resulting in 
inconsistent recovery (Tebbett and McCartney, 1988). 
The prevalence of illegal drug use in this country, as 
stated earlier, has necessitated the need to detect and 
identify drugs of abuse. This has brought about the rela-
tively new types of screening procedures. The accepted 
approach is to use preliminary screening tests, followed by 
more specific confirmatory assays. A wide variety of drug 
screening methods, each with its peculiar advantages and 
drawbacks may be utilized, including radioimmunoassay (RIA}, 
enzyme immunoassay (EIA} , thin-layer chromatography (TLC} , gas 
chromatography (GC}, high performance liquid chromatography 
(HPLC} , and fluorescence polarization immunoassay (FPIA} . 
FPIA has been used by the Abbott TDx instrument since 1981 for 
therapeutic drug monitoring and since 1987 for the screening 
of abused drugs (Jolley, 1981 and Caplan et. al., 1987}. A 
derivative of the TDx, the ADx, which is dedicated solely to 
screening specimens for the major classes of abused drugs, was 
introduced in 1988. (Caplan and Levine 1988}. And its entry 
into the forensic field has, therefore, been relatively recent 
(Table 2}. 
Immunoassays are based on specific antigen-antibody 
reactions. The primary advantage of immunoassay is its 
Table 2. FPIA Cocaine Metabolites Assay Sensitivity and 
Specificity 
1. Good Screening Method 
2. Benzoylecgonine Target Compound (inactive metabolite) 
3. Some Cross-Reactivity 
4. Semi-Quantitative 
TEST CPD. CONC. ADDED CONC. FOUND % CROSS-
(mcg/ml) (mcg/ml) REACTIVITY 
Cocaine 100.0 0.79 0.8 
10.0 0.04 0.4 
1.0 ND 
Ecgonine 10.0 0.03 0.3 
1. 0 ND 
Ecgonine 100.0 0.03 <0.1 
Methyl Ester 10.0 ND 
ND = None Detected 
14. 
(Concentration less than the sensitivity of assay 0.03 mcg/ml) 
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ability to detect small concentrations of drugs in body fluids 
and organs. This technique offers the best approach for 
detecting low drug levels associated with recreational drug 
use. The advantages of FPIA over other immunoassay methods 
such as radioimmunoassay (RIA) or enzyme multiplied 
immunoassay technique (EMIT) are nonradioactivity and stable 
calibration curves. 
Drug detection by FPIA uses an inverse relationship 
between polarization and concentration. The exceptional 
sensitivity and precision at low concentrations minimize 
false-positive and false-negative results (Cone et. al., 
1988). The Abbott instrument, the ADx, uses competitive 
binding and fluorescence polarization for detecting drugs of 
abuse in urine. A known amount of fluorescein-labeled drug 
competes with free drug in the sample for antibody binding 
sites. When bound to the antibody, the labelled drug rotates 
more slowly: thus, high levels of polarization correspond to 
low sample drug levels. Conversely, when the drug is free in 
the solution, it rotates more rapidly. Therefore, low levels 
of polarization correspond to high drug sample levels. The 
ADx measures polarization values and calculates the 
concentration from a previously stored calibration curve. The 
technology affords the screening of large numbers of samples 
at a time and yields a semi-quantitative result. 
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III. EXPERIMENTAL 
Medical examiner cases from January 1989 to June of 1989 
were reviewed. Pertinent data was recorded in spreadsheet 
format to easily refer to the cases and for summarizing 
results. There were 307 cases included in this investigative 
study, all analyses were recorded as well as medical examiner 
data of significance. The data that was recorded on the 
spread-sheet was as follows: the medical examiner case number, 
age, sex, race·, cause of death, manner of death, survival 
time, vitreous humor specimen available, urine specimen 
avaiable, urine immunoassay results, urine GC/MS results, 
blood specimen available, blood immunoassay results, blood 
GC/MS results (Appendix A). The cases that were selected to 
have vitreous samples analyzed met the following citeria: the 
vitreous sample had not previously been analyzed, and the case 
had cocaine and/or metabolites detected in blood or urine 
samples. 
Forty-eight vitreous humor samples were selected for this 
study. The vitreous specimens had been stored at -20° c. 
since being received in the laboratory from the medical 
examiner. There were four negative controls which were 
included in the study ;there was no cocaine and/or metabolites 
detected in the bloods or urines of these cases. 
The vitreous humor specimens were analyzed by fluores-
cence polarization immunoassay (FPIA) without any pretreat-
ment, dilution, or centrifugation. The Abbott ADx analyzer 
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was employed for the FPIA analysis. The calibrators, 
controls, and reagents were supplied by Abbott Laboratories. 
The instrument was operated in accordance with the Abbott 
operators manual for this instrument. Six calibrators were 
assayed and a valid calbration curve was derived by averaging 
the net polarization values (Figure 2). The assay requires a 
50 microliter sample to be run on the assay. The assertion 
was that the simplistic compositon of vitreous humor specimen 
would allow for this facilitated screening technique to be 
utilized. The sensitivity for the cocaine metabolite 
(benzoylegonine) assay was lowered to a threshold which 
allowed for low level positives in vitreous to be identified. 
This presumptive screening process has already been mentioned 
as one which detects the primary metabolite of cocaine, 
benzoylecgonine, in human urine specimens. 
demonstrates selective reactivity and 
The reagent system 
high specficity. 
Benzoylecgonine has a reactivity of 100%, whereas cocaine, 
ecgonine methyl ester and ecgonine cross react with the assay 
at less than 1%. The technique has superior sensitivity which 
allows for an adjustable minimum allowable threshold. Below 
this threshold, the safety zone extends to the stated 
sensitivity of the assay (McCord and Mccutcheon, 1988). The 
stated minimum allowable threshold for the cocaine/ 
benzoylecgonine assay is 0.30 micrograms per milliliter 
(mcg/ml) and the sensitivity of the assay is 0.03 mcg/ml or 30 
nanograms per milliliter which is based on the specifications 
of the instrument. 
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In forensic toxicology work, any preliminary or pre-
sumptive positive on an initial screening test must be 
confirmed by a confirmatory test. It is generally agreed in 
the forensic community that gas chromatography coupled with 
mass spectrometry (GC/MS) offers the best means for the 
unequivocal identification of drugs and their metabolites in 
biological materials. 
A Hewlett-Packard 5890 gas chromatograph interfaced with 
a Hewlett-Packard 5970 Series mass selective detector (MSD) 
was used for GC/MS analysis. The data system in use was the 
HP RTE-A computer system • The MSD was operated in the 
electron impact (EI) mode at 70 eV with an ion source temper-
ature of 280°C and an m/z range from 40 to 500. The instru-
ment was autotuned with perfluorotributylamine (PFTBA) 
(Appendix C) . The gas chromatograph column was an HP-1 coated 
fused-silica 12 m x 0.2 mm x 0.33-um film thickness. The GC 
was operated on a temperature program from 60° to 250°C, 
increasing at a rate of 30°/min and the injection was split-
less. The MSD was operated using electron impact ionization 
and in the selected ion monitoring mode (SIM). The ions 
monitored for each compound were 213 m/z and 210 m/z for 
benzoylecgonine-D3 (BZE-03 ) and benzoylecgonine (BZE), 
respectively and 185 m/z and 182 m/z for cocaine-03 (COC-03 ) 
and cocaine (COC) (Figures 3,4). In the selected ion 
monitoring mode the MSD can be set to monitor only those ions 
that are characteristic of the specific compounds. Since 
selective scanning permits the mass analyzer to dwell longer 
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22~ 
on specific masses, this mode is far more sensitive than total 
ion scanning. It permits analysis of selected compounds at 
very low levels in very complex mixtures - mixtures that may 
be too complex for resolution by gas chromatography alone. The 
rete~tion times obtained in the total ion chromatogram (TIC) 
were 9.11/9.12 and 9.66/9.67 min. for cocaine and benzoyl-
ecgonine, respectively (Figure 5). All standards were 
specialty analytical standards obtained from Radian Corpor-
ation. These were pure standards in methanol at a 
concentration of 10 mcg/ml. The standards included cocaine, 
trideuterated cocaine (cocaine-D3), benzoylecgonine, and 
trideuterated benzoyl-ecgonine (benzoylecgonine-D3). These 
standards were diluted accordingly to allow for a standard 
curve calibration from 25 ng/ml to 1.0 mcg/ml. There were 
three levels of control urine specimens run along with the 
research samples to validate the derived calibration curve. 
These controls (CON-DOA) were purchased from Diagnostics 
Products Corporation (DPC) and were in the following 
concentrations: 0.18, 0.36, and 1.5 mcg/ml. 
The confirmation procedure required the solid phase 
extraction (SPE) of the standards, controls, and samples. 
This was accomplished by the use of ExtrelutR extraction 
columns purchased from Analytichem International. These are 
disposable extraction columns designed for rapid sample 
preparation by a highly efficient liquid/liquid extraction. 
The SPE columns contain a specially modified form of diato-
maceous earth. The analytes in the aqueous samples are 
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adsorbed and distributed into a thin film over the hydrophilic 
packing. In this manner, background interferences 
are removed from the analysis. 
All standards, controls and samples were analyzed by the 
same cocaine/benzoylecgonine procedure (Appendix 0) adapted 
from Isenschmid (Isenschmid et. al., 1988). Into a clean 10 ml 
test tube, 1 ml of aqueous sample, 2 ml of phosphate buffer 
(pH 7.0), and 100 microliters of internal standards (COC-03 
and BZE-D3 at concentrations of 500 nanograms each) are 
pipetted. This chemical cocktail is vortexed and added to an 
SPE extraction column. The mixture is adsorbed for 4 to 5 
minutes. The analytes are eluted into a disposable 15 ml 
centrifuge tube with two aliquots of 9:1 chloroform: 
isopropanol. The sample is then evaporated to dryness in a 
heated waterbath (50-60°C) under a stream of nitrogen to 
prevent oxidation. After dryness, the benzoylecgonine (if 
present) is derivatized to n-propyl cocaine by boiling over an 
open flame with 100 microliters of n,n-dimethylformamide-di-n-
propyl acetal for 30 seconds (Figure 6). When cool, 1 ml of 
lN sulfuric acid is added to the tube and it is mixed well. 
The sample is cleaned up to remove impurities when 3 ml of 
toluene: heptane: isoamyl alcohol (76:20:4) is added to the 
aqueous portion, mixed and the organic layer is discarded. The 
aqueous portion is next neutralized with 2 ml of sodium 
carbonate buffer (pH 9.0). The sample is extracted with 3 ml 
of the toluene: heptane: isoamyl alcohol mixture, mixed and the 
organic phase is transferred to a clean conical centrifuge 
J{cooH 
·o-c-@ 
II 
0 
Fig. 6. 
NCK, 
#c-o-~H,CH,CH, It 0 
. o-c ·/& n~ 
0 
REACTION !=OF! Tl-1E DERIVATIZATIOl-4 OF BENZOVt..ECGONINE TO 
111-PROPYt.. COCAINE 
25. 
Callb rtht crNANC11D' 
Cal1b Oa\e1 91972• 9812' 
toapa COf. t 
4. 
Cone, 3. 
UG""~ 
3, 
2. 
2. 
1. 
1. 
Co•p • I -- AY•r•s• 1tr 
-·-·- 1• \ 0•9~•· 
·--- -··- 2nd D•s,.•• 
1.1 1.1 2.e 3,1 4.1 11.e 6.1 1.8 8.1 9.111.111.812.913,e 
Response Ratio 
Col'lpound a Cal1b File: CFNANC::05 
Co~pound: COCAINE 
I1td: COCAINE-03 
File: >719A2 >719113 >719A4 >719A5 >719A6 >719A7 >719A8 >719119 
Cone: .0250 .0500 .0750 .100 .250 .500 .750 1.00 
Rf: 1.5-479 I .-4967 1.-4160 I . -4 I 80 I .3995 1.3667 1.2718 1.3549 
>71980 >71981 
2.50 5.00 
1.1345 1 .1564 
Average of 18 Rf11 
1st Degree Equation: 
1st Degree Corr Coef: 
2nd Degree Equation: 
2nd Degree Corr Coef: 
1.3563 ( 9.89 X Rad) Rx: .0000000 Ry: .0000000 
y • -.101261 + .8729581<x> 
.9993153 
y • -.07-4080 + .8"408837Cxl + .0028910cx·2l 
.9993689 
In the above equat1on1: 
Cone Std Area Std · 
y • ---..------ )( . ---------Cone Istd Area Iatd 
Istd Cone tor all cal1bration points is: .500 
Fig. 7. Calibration CUrve of Cocaine by OC/MS 
26. 
C•llb rtl•• crNANC1105 Co•p • t 
Caltb Da\&I t117t4 ,,,,, 
-- Ava,.a1a Rr 
-·-·· 1• l o.,,. •• 
Coapt I ~ECIDMINt PRO'Y\. Otl 
-- tnd Oa1,.•• 
1.1 t.a 3,1 •.1 a.a '·' 1.1 a.a •·• 11.1 11.1 
Response llaUo 
Co"pound I 2 Cal1b Ftl11 CFHANC:105 
Co~poundl SENZOYL£C60NINE PROPYL DER 
latd: SENZDYLEC60NINE PROPYL DERIV. 
File1 >719A2 >719A3 >719A4 >719A5 >719A6 >719A7 >719A8 >719A9 >71981 >71981 
Cone: .e25e .e5ee .175e .1e1 .251 .see .751 1.11 2.51 5.ee 
Rf: .89391 .83442 .79362 .81493 .85639 ,87263 ,82132 .81217 .98439 .92177 
Averege ot 10 Rta: 
lat Degree Equetion: 
lat Degree Corr Coef: 
2nd Degree Equation: 
Znd Degree Corr Coet: 
.85145 < 5.31 x Rid> Rx: .1111111 Ry: .eeeeeee 
y • .8685782 + 1.883689(x) 
.9996432 
y • .1251851 + 1.158812Cx> + -.te8517<x"2> 
.9998112 
In the ebove equeUon11 
Cone Std Area Std 
y 
. ---------
)( 
. ---------Cone Iatd ArH latd 
Iatd Cone for- •11 celibr-at1on pointa 11: .SH 
Fig. 8. calibration Curve of Benzoylecgonine by OC/MS 
27. 
28. 
tube and evaporated to dryness under a stream of nitrogen. 
The dried sample is then reconstituted with 100 ul of chloro-
form and 3 ul are injected into the GC/MS for mass spectral 
analysis. 
Standard curves for cocaine and benzoylecgonine were 
established by running series of standards from 25 to 1000 
ng/ml (Figures 7,8). The calibration curve for benzoyl-
ecgonine produced a slope of 1. 083, 
correlation coefficient of 0.999. 
zero intercepts and a 
The procedure was 
determined to be reliably linear for concentrations between 
0.030 and 1.00 mcg/ml. Quantitations for the analytes were 
achieved by comparing the abundance of the major ions and 
retention times of the selected ion · chromatogram of the 
analytes with the corresponding internal standard (Table 3). 
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IV. RESULTS 
From the 307 cases researched, 48 were selected to be 
included in this study. These cases were selected to analyze 
for the concentration of benzoylecgonine in the vitreous 
humors and to compare these to the blood concentrations of the 
same analyte. Of these selected 48 cases, 3 were determined 
to have vitreous samples that were of insufficient quantity to 
allow for FPIA and GC/MS determinations. This allowed for 45 
samples to be selected to be analyzed by FPIA and GC/MS. 
These samples included four negative controls, which gave FPIA 
readings of zero. 
For the purpose of this study, any FPIA reading greater 
than zero was initially considered a positive, which required 
further testing. Of the total cases reviewed (n = 307), 41 
vitreous results by FPIA were obtained, which represented 
approximately 13% of the total cases. These vitreous positives 
by FPIA were separated into three categories (Table 4). The 
first category which represented 7.3% of the 41 samples had 
FPIA readings > o but < 0.03 mcg/ml. The second category 
which comprised 41.5% of the samples had FPIA readings > or= 
to o. o 3 mcg/ml but 1 ess than O. 3 O mcg/ml (the standard 
threshold level). The third category was the vitreous humors 
with FPIA readings > or= 0.30 mcg/ml, and this accounted for 
51.2% of the cases. 
The majority of the vitreous humors tested were above the 
standard threshold level of 0.30 mcg/ml. However, a signi-
Table 4. Medical Examiner Cases with Vitreous Humor 
Samples Analyzed for Cocaine Metabolites 
87% Medical Examiner Cases - Vitreous Humor Samples 
negative 
13% Medical Examiner Cases - Vitreous Humor Samples 
> O mcg/ml (n=41) 
7.3% FPIA < 0.03 mcg/ml 
41.5% FPIA readings > or = 0.03 mcg/ml 
51.2% FPIA readings > or = 0.30 mcg/ml 
31. 
32. 
ficant number of samples, 41%, fell between greater than 0.03 
mcg/ml and less than 0.30 mcg/ml. If only vitreous humor was 
analyzed for these cases, these would not have been further 
investigated under conventional forensic toxicology 
guidelines. 
The vitreous humor initial screening results were 
compared with benzoylecgonine levels determined by GC/MS. An 
attempt was made to see if a correlation existed between the 
FPIA technique (which screens primarily for benzoylecgonine} 
and the benzoylecgonine level determined by solid phase 
extraction and analysis by GC/MS (Table 5). The correlation 
coefficient for the two assays was 0.701 (Table 6). Although 
there was relationship between the two assays, there were 
several outliers (Figure 9). A correlation is a mathematical 
statistic that indicates the degree to which two variables are 
associated. If the correlation is squared (which varies from 
o.o to 1.0), then one gets a mathematical description of the 
proportion of one variable that explains the occurrence of the 
second variable. The scatter plot amd the regression line are 
shown in Figure 9. 
The GC/MS results of the vitreous humor samples were then 
compared with the GC/MS results of the corresponding blood 
samples (Table 7). Specifically, the benzoylecgonine 
quantitations were compared to calculate the correlation 
coefficient between the two analyses. The correlation between 
these two biological specimens for the same analyte was 0.510 
(Table 8). The scatter plot and the regression line are shown 
33. 
Table 5. Data showing Vitreous Humor Sample l.D. # , FPIA Reading, and GC/MS 
Benzoylecgonine Quantltation 
l.D. # FPIA GC/MS 1.0.# FPIA GCMS 
1 ME0122 0.00 0.00 39 ME1838 1.05 1.02 
2 ME0354 0.00 0.00 40 ME0814 1.08 1.29 
3 ME0118 0.00 0.00 41 ME1530 1.29 2.71 
4 ME0311 0.00 0.00 42 ME1935 1.38 0.83 
5 ME1665 0.01 0.00 43 ME0006 1.80 2.38 
6 ME0453 0.02 0.03 44 ME0260 2.01 2.87 
7 ME1557 0.02 0.23 45 ME1901 2.59 0.90 
8 ME0328 0.03 0.09 
9 ME1571 0.03 0.04 Units = mcg/ml 
10 ME0976 0.03 0.01 
11 ME0878 0.03 0.03 
12 ME0443 0.05 0.27 
13 ME0965 0.05 0.29 
14 ME2027 0.08 0.03 
15 ME1653 0.10 0.21 
16 ME1090 0.11 0.17 
17 ME0027 0.11 0.16 
18 ME0536 0.14 0.26 
19 ME0092 0.18 0.29 
20 ME0007 0.21 1.71 
21 ME1229 0.23 0.24 
22 ME0727 0.24 1.07 
23 ME1676 0.24 0.31 
24 ME0820 0.26 1.16 
25 ME1512 0.33 0.39 
26 ME1812 0.33 0.57 
27 ME1440 0.41 1.07 
28 ME2009 0.50 0.17 
29 ME0175 0.51 1.11 
30 ME1991 0.51 0.65 
31 ME1899 0.52 0.47 
32 ME0156 0.54 1.28 
33 ME0287 0.80 0.86 
34 ME1811 0.85 0.41 
35 ME0286 0.90 1.01 
36 ME1186 0.98 0.54 
37 ME2005 0.99 1.23 
38 ME1855 1.02 0.58 
Table 6. Linear Regression Analysis of Vrtreous Humor 
FPIA vs. GC/MS Results 
Regression Output: 
Constant 0.118228 
Std Err of Y Est 0.429233 
R Squared 0.497603 
No. of Observations 45 
Degrees of Freedom 43 
X Coefficient(s) 0.595707 
Std. Err of Coef. 0.091281 
Correlation coefficient o. 701 
34. 
35. 
FPIA COC Metabolites(mcg/mi) 
• 0 0 0 ..... ..... ~ I\) w (') 
(JI 0 ()1 0 (JI 0 (JI 0 
I 0 0 0 0 0 0 0 0 0 
0 3 
" 
~, 0 "C 
..._ tu 
SS: 01 ""'I 
"' 
. I 
-· o ---i-- (J) 
Cl 01 + 0 N II :s m pl + ,, 0 
r- gl *- - "'""' ct> )> 
< < C1) 
+ < -· 
-
.....
"' 
"""' 
_L (,b ""'I I 
-
0 • (1) 
3 0 C>o 
(') + 0 c: (Q 
-- en ..._ ..... 3 
:r 
ii: :c 
- UJ c ._.. + ::J 3 t! 0 
;i .i:. """ Ol r-(£) < (f) 
l + -th 
_L p I 
0 
0 
Fig.9. Scatter plot of Vitreous Hurror Levels by FPIA vs. GC/MS 
36. 
Table 7. Data of Vitreous Humor Benzoylecgonine levels 
by GC/MS and Blood Benzoylecgonine Levels by GC/MS 
l.D. # Vitreous Humor Blood 1.0.# Vitreous Humor Blood 
GC/MS GC/MS GC/MS GC/MS 
ME1665 0.00 0.00 *0.00 BZE IN. URINE··:· 41 ME0814 1.29 1.52 
2 ME0122 0.00 0.00 *NEG CONTROL 42 ME0007 1.71 1.34 
3 ME0354 0.00 0.00 *NEG CONTROL 43 ME0006 2.38 0.56 
4 ME0311 0.00 0.00 *NEG CONTROL 44 ME1530 2.71 2.03 
5 ME0118 0.00 0.00 *NEG CONTROL 45 ME0260 2.87 0.60 
6 ME0976 0.01 0.06 
7 ME2027 0.03 0.33 
8 ME0878 0.03 0.10 Units = mcg/ml 
9 ME1571 0.04 0.07 
10 ME0328 0.09 0.10 
11 ME0027 0.12 0.46 
12 ME2009 0.17 0.00 *0.40 BZE IN URINE · 
13 ME1090 0.1 7 1.12 
14 ME1653 0.21 0.14 
15 ME1557 0.23 0.04 
16 ME1229 0.24 0.13 
17 ME0536 0.26 0.59 
18 ME0443 0.27 0.07 
19 ME0965 0.29 0.72 
20 ME0092 0.29 0.12 
21 ME1676 0.31 0.76 
22 ME0453 0.03 0.00 *0.34 BZE IN URINE . 
23 ME1512 0.39 0.45 
24 ME1811 0.41 0.42 
25 ME1899 0.47 0.42 
26 ME1186 0.54 0.56 
27 ME1812 0.57 0.25 
28 ME1855 0.58 0.53 
29 ME1991 0.65 0.71 
30 ME1935 0.83 0.82 
31 ME0287 0.86 1.92 
32 ME1901 0.90 0.77 
33 ME0286 1.01 0.34 
34 ME1838 1.02 2.1 9 
35 ME0727 1.07 0.60 
36 ME1440 1.07 1.42 
37 ME0175 1.11 1.60 
38 ME0820 1.16 0.29 
39 ME2005 1.23 4.52 
40 ME0156 1.28 1.06 
Table 8. Linear Regression Analysis of Vitreous Humor Benzoylecgonine Levels 
by GC/MS and Blood Benzoylecgonine Levels by GC/MS 
Regression Output: 
Constant 0.355201 
std Err of Y Est 0.617418 
R Squared 0.260023 
No. of Observations 45 
Degrees of Freedom 43 
X Coefficient(s) 0.426367 
std. Err. of Coef. 0.111333 
Correlation Coefficient 0.51 
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in Figure 10. 
All four negative controls correlated well by FPIA and 
GC/MS, therefore exhibiting no false positives. In two cases, 
the FPIA results on vitreous humor were positive, yet the 
corresponding blood samples were negative. In these two 
cases, the urines were positive for benzoylecgonine, therefore 
it might indicate a lag time in the elimination of the drug. 
This has been demonstrated in the laboratory for other drugs, 
such as ethanol (Caplan and Levine, 1990). One case gave a 
positive FPIA result in vitreous (O.Ol mcg/ml), and no 
benzoylecgonine was detected by GC/MS. Technically, due to 
the limits of the assay this is below the O. 03 mcg/ml 
senstivity of the assay and therefore would not be considered 
a true false positive. Both the blood and the urine in this 
case were negative for the presence of benzoylecgonine (Table 
9) • 
The confirmation analyses provided full concordance data 
between the two assays. The DPC controls run to validate the 
GC/MS calibration curve gave accurate quantitations. (Table 
10) . 
Table 9. Summary of Analyses of Data from 
Vitreous Humors by FPIA and GC/MS. 
* 307 Medical Examiner Cases reviewed 
* 48 Cases selected for vitreous humor analyses 
40. 
* 3 Cases - Vitreous humors had insufficient quantity 
for GC/MS quantitations 
* No false negatives by FPIA 
* No false positives at 0.03 mcg/ml cut-off by FPIA: 
(2 Cases - Vitreous humors - FPIA positive 
GC/MS positive 
Blood samples negative * Urines positive *) 
(1 Case - Vitreous Humor - FPIA result 0.01 mcg/ml 
GC/MS none detected) 
41. 
Table 10. Accuracy check wrth Diagnostics Products Corp. 
GC/MS Control Samples 
TARGET (NG/ML) .. ACTUAL VARIATION ' 
CON-DOA LEVEL 1 180 185 +!-5 NG/ML 
CON-DOA LEVEL2 360 362 +/-2 NG/ML 
CON-DOA LEVEL3 1500 1550 +!- 50 NG/ML 
(GC/MS ANALYSIS) 
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An additional study was conducted to determine the 
possible explanation for the variation in some cases between 
the vitreous humor FPIA result and the GC/MS result for 
benzoylecgonine. The first assumption was that the variation 
in the vitreous FPIA result was due to the viscosity factor. 
This factor could cause the variation in the instrumental 
pipetting which occurs in the FPIA technique. 
A pooled reserve of human vitreous humor was obtained 
from samples to be discarded by the Acting Chief Medical 
Examiner. The pooled vitreous samples equaled a volume of 50 
milliliters. The pooled vitreous humor was run by FPIA 
initially with no drug added, to ascertain the blank reading 
to insure that there were no drugs present that would give a 
positive reading. The sample was run in 20 repetitions and 
the results were consistently negative. The pooled sample was 
then spiked with benzoylecgonine standard to attain a concen-
tration of 1.6 mcg/ml. This sample was separated into two 
equal volumes, one was untreated and one was treated with 10% 
trichloroacetic acid (TCA). The TCA could potentially remove 
the protein, thereby possibly eliminating the viscosity factor 
as a cause of the inconsistencies. However, the CVs for both 
aliquots were 2. 9% and 3. 3% respectively (Table 11). The 
aliquot treated with 10% TCA demonstrated a reduced positive 
result. The mean for these 20 repetitions was 1. 07 mcg/ml, as 
opposed to the aliquot mean of 1.61 mcg/ml for the untreated. 
It was thought that the addition of a proteolytic agent 
would eliminate the viscosity factor and allow for better 
Table 11. Precision Study of pooled Vitreous Humor samples-
untreated and treated with 10% Trichloroacetic Acid 
•UNTREATED VH 1W/ 10% TCA 
TARGET VALUE (MCG/ML) 1.60 * 
MEAN 1.61 1.07 
STD.DEV. 4.6 3.5 
COEF. OFVAR. (%) 2.9 3.3 
#OF TRIALS 20 20 
MEAN NET POLARIZATION 112.46 *129.86 
VALUE BY FPIA 
*ALTERED NET POLARIZATION 
READING BY FPIA: 
QUANTITATION LOWERED 
43. 
44. 
correlation between the vitreous humor FPIA result and the 
vitreous humor benzoylecgonine result by GC/MS. Trichloro-
acetic acid was selected as the agent, since it is commonly 
used in the laboratory to precipitate out proteins found in 
blood samples. The selection of 10% TCA was not a good choice 
since the solution could react with benzoylecgonine (a 
tertiary amino carboxylic acid) and produce a salt, thus 
interfering with the extraction of the analyte. The phenyl 
ester on benzoylecgonine could also be de-esterif ied and the 
resulting product, ecgonine, does not react significantly with 
the immunoassay. The agent ( 10% TCA) also exhibits some 
fluorescence, which would adversely affect the FPIA analysis, 
by causing a decrease in the quantitation. There were no 
inconsistencies exhibited by either aliquots, and they yielded 
low CV's. The most unusual finding was that the addition of 
10% TCA increased the net polarization and therefore decreased 
the cocaine metabolite concentration by FPIA. The study could 
not duplicate the individual viscosity problem experienced 
when sampling the low volume vitreous samples. 
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V. DISCUSSION 
Fluorescence polarization immunoassay of vitreous humor 
as a screening process provided a qualitative prediction of 
the final GC/MS results. There were no false positives or 
false negatives by using this screening process. The initial 
perception of a false positive ultimately proved to be below 
the limits of the assay•s cut-off level. 
The correlation coefficient between vitreous humor 
benzoylecgonine levels and blood benzoylecgonine levels was 
0.5. Ideally, if the drug substance is distributed by simple 
diffusion, at equilibrium the blood and vitreous humor levels 
should be identical. Studies by Coe, indicated more variation 
between blood and vitreous humor levels (Coe and Apple, 1985) . 
He also indicated potential difficulty in separating toxic 
from therapeutic levels of drugs based on vitreous humor 
levels alone. 
From the data generated by this research and those of 
others, several generalizations may be made concerning the 
concentration of drugs in vitreous humor. The more water 
soluble drugs and those least affected by protein-binding 
factors in the blood, would be expected to readily diffuse 
from the blood into the vitreous humor. The drugs must have 
sufficient lipid solubility to penetrate the blood-vitreous 
barrier. In some cases in the study, the high water 
solubility of benzoylecgonine permitted high concentrations to 
be found in the vitreous, sometimes even higher than in the 
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blood. There are other factors causing the variation in the 
distribution of the metabolite in the blood and vitreous 
humor. survival times of the decedents is a definite factor, 
along with the time since the administration of the drug, the 
presence of other drugs in the system, the varying states of 
decomposition, and also the perimortem interval. It was 
demonstrated by Beno that by sampling vitreous at different 
perimortem intervals, the drug content of one vitreous humor 
could vary greatly from the other vitreous (Beno and Kriewall, 
1989). This variation could be due to the leaching of the 
drug from the high concentrations of the drug in the brain 
tissue. 
The history in most of the cases did not afford the 
survival time information. In the majority of the cases, the 
survival time was unknown and therefore did not clarify the 
disparity between the two fluids. As mentioned in other 
studies, it had been predicted that when survival times were 
lengthy, the blood/vitreous ratio of an analyte might approach 
unity. However, this research did not clarify that assump-
tion. Since vitreous humor is a partitioned fluid, with a 
Tl/2 of 10 to 15 minutes, the author anticipated a good 
correlation with corresponding blood levels. Also, since the 
molecular weights of benzoylecgonine and cocaine are 
relatively low, 289 and 303 respectively, these low molecular 
compounds could diffuse rather easily. However, the ratio 
varied a great deal between the two biological fluids. There 
are more factors involved, and the most important probably 
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being the difference between dosing and the time of death as 
indicated in the study by Poklis (Poklis et al., 1985). 
The most troublesome finding was the variation between 
the vitreous FPIA result and the vitreous GC/MS benzoyl-
ecgo~ine quantitation. The FPIA technique is a semi-
quantitative technique which reacts 100% with the compound 
benzoylecgonine. However, cross reactivity with other 
compounds does occur at a low percentage. The other compounds 
if present in varying high concentrations, may be causing the 
apparent discrepancy between the two assays. The additional 
study with 10% TCA did not clarify the problem, since there 
were no inconsistencies demonstrated that could be attributed 
to the viscosity factor. 
which must be explained 
The variation appears to be one 
on a case by case basis. The 
outstanding outliers in the study were reviewed and most 
demonstrated no known survival time or time since dosing based 
on the history. 
The biggest liability in the screening of vitreous humor 
is the lack of sufficient sample volume to repeat analyses and 
generate statistical data on a case by case basis. The low 
sample volume did not allow for repetitive analyses, which 
then would allow for CVs to be calculated on each sample. 
This is not true of blood and urine, which when available, are 
usually of sufficient volume. 
One point for discussion is the validity of testing 
infants and children by vitreous humor for cocaine exposure 
in the absence of a urine sample. Lowering the threshold 
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as was done in this study, to a level of 0.03 mcg/ml would be 
necessary to detect the low levels of cocaine and metabolites 
found in infants and children. In 25 cases reviewed of 
maternal substance abuse, all showed benzoylecgonine levels in 
the blood of the fetuses and neonates in the range of 0.12 to 
3.2 mcg/ml (Sweeney, 1991). The routine drug screening of 
infants and children would now appear to be a modern 
necessity. 
49. 
VI. SUMMARY AND CONCLUSIONS 
The goal of the research was to provide a valid 
assessment of the fluoresence polarization immunoassay techni-
que in detecting cocaine and/or its metabolites in vitreous 
humor. In all the cases reviewed, when cocaine and metabo-
lites were present in the blood, cocaine metabolites were 
positive by FPIA in the vitreous humor. The research showed 
vitreous humor to be a reliable postmortem specimen for 
detecting antemortem cocaine use. It was demonstrated that 
elevated cocaine metabolite (benzoylecgonine) levels in blood 
are accompanied by elevated cocaine metabolite levels in 
vitreous humor. The research illustrated that the cocaine 
metabolites assay by FPIA has sufficient specificity and 
sensitivity to be a valid screening technique for vitreous 
samples at the low threshold of 0.03 mcg/ml. 
The screening of vitreous humors by FPIA when the 
threshold is lowered, is a useful tool in forensic toxicology. 
The technique, however, is just a screening one and not meant 
to replace the confirmation of the result. When the absolute 
concentration of benzoylecgonine is critical for the interpre-
tation of results, an alternate, more specific methodology 
should be used for an accurate concentration; GC/MS is such an 
alternative. 
Vitreous humor specimens provide an additional medium for 
analysis in postmortem cases. These specimens can be screened 
rapidly and relatively inexpensively by fluorescence 
so. 
polarization immunoassay for qualitative results. There are 
more studies necessary on the ability to detect various drugs 
in vitreous humor. In the future, vitreous drug concentrations 
when compared with blood concentrations, may allow for the 
assessment of the time between administration of the substance 
and death. 
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APPENDIX A. 
COMPARATIVE TOXICOLOGY OF VITREOUS HUMOR AND BLOOD 
[ CASES ~-Ag:E Mti,N·f~ w~~~1 ~~1 ~~~+-YJks-~~~ E-_!!itES.~ 9fft¥k- ~ roEATH; DEA!H _(HR.) {M_CG/~!L- -=~- -J~SG/!'v!!,J : jJ 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
JANUARY"89 
ME0004-89 
ME0005-89 
PEND 
ALC 
M~<<}rfl 
'Ml?.Q(m-8.9" ;' . PBNp •• 
ME.0010-89 JNJ 
ME0014-89 ASHD 
ME.0017-89 COi 
MB0027-89" . PBND 
ME0028-89 JNJ 
ME0034-89 
ME0047-89 
ME0062-89 
ME0066-89 
ME0076-89 
Ml10080-119 
MEOORJ-89 
M E0092-89'" 
ME0118-89-
MEOJ22-8!;1'" 
ME0139-R9 
MEOJ5U-89 
MBOIS6-89'" 
MEOIW-89 
INJ 
INJ 
ASHD 
SIDS 
PEND 
OD 
!NJ 
ASPX 
INJ 
PEND 
lNJ 
GSW 
PEND 
ASllD 
PEND 5M/W/M NONE y NEG 
NAT S&'W/M UNK Y N/A 
.· .:~~·J·.f> :::. :: ~~~ ' <;·:;_;. .;j:;;::i. :~=:t~:~ .. :::::< t~:: ·;: :' 
HOM 
NAT 
ACC 
PBND 
ACC 
ACC 
MVA 
NAT 
SIDS 
PEND 
SUIC 
MVA 
SUIC 
MVA 
PEND 
SlJIC 
SUIC 
PEND 
NAT 
46/W/M NONE 
6418/F NONE 
76/W/F 
37/W/M 
75/W/F 
0.5 
NONS 
NONE 
42/W/M NONE 
63/W/F &O 
57/W/M NONE 
IM/W/M MINS 
llM/W/M NONE 
43/W/M NONE 
83/W/F NONE 
27/W/M NONE 
30/W/F MINS 
33/W/M NONE 
64/W/F 300AYS 
SHIW/M NONE 
35/B/M &O 
.~1/W/F NONE 
y 
y 
y 
' y 
y 
y 
y 
y 
y 
y 
N 
y 
y 
y 
y 
y 
y 
y 
y 
N/A 
NEO 
BARBS 
•0.11 COCMETS. 
N/A 
NEG 
PPX 
NEG 
N/ A 
NEG 
N/A 
N / A 
•O.J8COC.METS 
•NHG/l.OW 
•Nl!.v/LOW 
NEG 
N/A 
•0.54 COCME'fS 
NEG 
NIA 
o.t6Att 
N/A 
0.30 RZE! 
O.OORZE 
o.oonze 
1.2'\BZE 
NOD 
N/A 
.0.05COC'JQ.56l3ZB 
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QNS 
N/A 
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24 MEIJl75-89"' ASPX SUIC 37/W/fl NONE y •o.st COCME'fS 1.11 Bl..H o. :nCOC/().53EME/1 .6f\ZE 
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28 ME0240-89 COi ACC 43/W/M NONE y N/A N/A 
29 ME0247-89 ASPX StJIC 1'>/W/M NONE y N/A N/A 
30 ME0249-89 PE!ND SIDS 3M/W/F 0.5 N N/A N/A 
31 ME0252-8'> ASPX MVA 15/W/F NONB y N/A N/ A 
32 ME0260-89'" GSW SUIC 28/WIM MINS y •z.ot COC.METS 2.87 A7.11 O.OSCOC/0.601, MP,/2.SBZB 
33 ME0261 ·!19 PEND PEND 56/0/ M NONE y NEG NDD 
34 ME0265-89 INJ AC:C 46/W/'f' 0.5 y NEG NIJD 
35 ME0278-89 PEND PEND 7WK/WIM NONE N N/A NDD 
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38 ME0289-89 ASHD NAT 40/W/M NONE y N/A N/A 
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40 ME029'J-89 INJ ACC 80{Wlf' 1.0 y NEG NDD 
41 ME030t -8<J PE!ND PEND JlM/ll/M MINS y NEG N/ A 
42 ME0310-89 ALC PEND 43/W/F NONE y N/A NIA 
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44 MP.0312-89 ASHD NAT 39/WIM NONP.. y N/A NIA 
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46 ME0'.328-89" GSW SUIC 37/W/F NONE y •o.m CDC.METS 0.0907.El. 0.08COC/O. IOBZI\ 
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83 ME0592-X9• GSW SlJIC 3VW/M NONE y •QNS ONS NEGCX)C/0.33AZE 
84 ME0.597-89 cc·1· ACC 23/W/M <1.0 y N/A N/A 
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111 ME0820-8!r 00 PEND 26/W/M 36HRS y •().26 C'OCMETS 1.16 nze. O.tlRCOC/1~29AZE 
L1) 
L1) 
I 12 MEOR22-ll'} 
113 MEOX63-1N 
114 Ml '.0~6-IN 
115 ME0878-x~ 
116 ME01<92- X9 
117 ME0.~93 -R'I 
1 18 MEU895-R9 
119 ME0905-IN 
12() M E0912-X'J 
121 MEO<J13-R9 
122 MEU922-X9 
123 ME0939-R'> 
124 ME0940-IN 
125 M E 09 45-89 
126 ME0960-8'1 
127 ME0%5-8!1" 
128 ME()t'n6-f19• 
129 ME0983-89 
130 ME0985-fl'I 
J 31 M E 0986-89 
132 MEO'J'.16-8 '> 
133 ME0'.197 -X'> 
134 MEl()(ll -89 
135 ML!llKIH l'I 
136 ME10l5-X'> 
137 MEIOZ0-89 
138 MP.1041 -x•r 
139 ME1042-R'I 
140 ME1047-R'I 
141 MP.1051 -X'I 
/\SPX 
COl 
INJ 
OD 
INJ 
DH.OWN 
ccr 
C'C'T 
!'END 
PEND 
/\Sl'X 
Or{ OWN 
DROWN 
PEND 
/\SllD 
AS' IM 
OD 
/\Sl'X 
CCT 
CXT 
DROWN 
DROWN 
/\SPX 
CC:T 
ALC 
ASllD 
PEND 
GSW 
IN.I 
/\SI-ID 
SlllC 
ACC 
SIJ IC 
l JNCL/\SS 
/\C C 
/\CC 
ACX; 
/\('( . 
Pl '.ND 
PEND 
ACX: 
J\C:C 
Sl llC 
PEND 
AC :c 
PEND 
PEND 
SUIC 
/\CC 
ACX; 
/\CX : 
ACC 
/\C:C 
ACC 
NAT 
ACC 
PENrJ 
llOM 
/\CC 
NAT 
2UIOIM 2 HRS 
'JMO/W/ M NON E 
34/WIM 0.5 1-ll{S 
26/W/ M 16DAYS 
59/W/F 40 MINS. 
82/W/ M NONE 
19/WI M NONI ', 
73/WIF NONE 
67/ BIM NONE 
75/ W / F NONE 
13MO/WI NONE 
24/WIM 
56/WI M 
311BIM 
41/W/ M 
3 51WIM 
19/W/M 
22/W IM 
34/WIF 
NONE 
NONE 
NONE 
NONE 
NONE 
NONE 
NONE 
>7 llRS 
64/WIF NONE 
11/WIM NONE 
I l l M/W NON E 
801W IM MINS 
R'O/W!M DI\ YS 
451BI M NONE 
50/WIM NONE 
31 WK/WI NONE 
171W/M 
281/B/M 
<>3/ 14/M 
MINS 
NONE 
NON E 
y 
y 
y 
y 
y 
y 
y 
y 
N 
y 
y 
y 
y 
y 
y 
y 
y 
y 
y 
y 
y 
y 
y 
N 
y 
y 
y 
y 
y 
y 
NI A 
QNS 
NI A 
•0.03 COC.Ml3TS 
NI I\ 
NI A 
NIA 
Ol'IATES 
NIA 
NIA 
NIA 
Nit\ 
NEG 
NIA 
NI A 
•o.os COC.METS 
•0.03 C'OC. METS 
N/ A 
NEU 
N /A 
NI I\ 
NI A 
NEU 
NIA 
NIA 
NI A 
•oNs 
NI A 
NI A 
NII\ 
0.03 R7.f! 
0.2913ZE 
0.01 B7E 
QNS 
LID/ Pl 11 '.NY 
NDD 
I O.OAMOBARBITt\l . 
•BIL-0 .l 9COC/0. IOBZ1 l 
NDD 
NDD 
NI I\ 
0.05Fl{r\ECX>D/0.31TOTCOD 
0. 02:~1 l/\LOPERIDOL 
NIA 
NDD 
NIA 
0.07FU JOXE'l'INE/. I '.\NORFI .UOX 
NIA 
NOD 
0. I J COC/O. 7213Z:I:: 
0.09COC/ O. 0613ZE 
NI A 
NIA 
N i l\ 
NI A 
N /J\ 
NDD 
NI A 
0.0~5/\LPRAZOl .AM 
NDD 
O.~IJCOC/I. I 2137.l:l 
4. 1 NG/MLTl~C/ 1 6TIK:C 
NI A 
NI A 
\0 
11')-
142 ME1056-89 AS'IM NAT 23/W/M NONE y NIA 2211-IEOPHYLl .INE 
143 ME1062-89 PEND PEND 20/W/M 42HRS N NIA l.8CARBAMAZRPINE 
144 ME1066-89 PEND PEND 4MO/W/F NONE y NEG NIA 
145 ME1070-89 GSW HOM 111BIM 2DAYS y N EG 7.l!PHENYTOIN 
146 ''MEt090-s9" cx::r ACC.: ': 19/W/M <iHR . : y : : •0.11 coeMan: 0.17 BzB · .. : ,O.OSCOt'./O.~ilZE 
147 ME1091 -89 COi ACC SO{B/M NONE y NEG NIA 
148 MEl~ DIS NAT 31/W/F NONB y NEG LIDOCAINE 
149 MB1097-89 DJS PEND 47/W/M NONB y NIA NIA 
150 ME1104-89 PEND PEND 2S/W/M NONB y NEG ACETONEllSOPROPYL 
151 ME1128-89 INJ ACC 44/W/M 6DAYS y NIA NOD 
152 ME114S-89 GSW SUIC 19/W/F NONE y NIA LIDOCAINE 
153 MEUS0-89 DJS NAT 6MO/W/F NONB y NIA QNS 
154 MB1142-89 ASHD NAT 8S/W/F NONE N NIA ACETONE 
155 ME.1162-89 ASHD NAT S3/W/F NONE. y NEO 0.13VERAPAMIL 
156 MB116S-89 OD PEND S4/W/F NONB y OPIATES 0.4SFREBCODl1.STOTCOD 
157 ME1086-89 ALC NAT 481W/M NONE. N NIA NOD 
April '89 
158 ME1176-89 COi AC'C S9/W/M NONE. y NIA 44.8%HBCO 
159 ME1177-89 COi ACC 49/W/M NONE y NIA 46.9%!-IUC.:0 
160 M E118S-89 OD UNO ASS Sl/W/M 4HRS y NIA NIA 
161 ME1186-8'1" OD UNCt..ASS 24/WIM NONB y •0.98 COC.MB'rs O.S4BZl! 0.07COC/0.56B:t..E 
162 ME1190-89 INJ AC'C 18/WIM <I llR y NIA NIA 
163 M E.1210-89 ASl-ID NAT 6Cl/WIM NONE y NIA NIA 
164 M E12 11 -89 ALC NAT 84/WIM NONE y NEG NDD 
165 Ml31226-89 INJ ACC 74/W/M NON E y NEG I .IDOCAINE 
166 ME1228-89 lNJ ACC 41/W/M NONE y N EG NIA 
167 ME1229-89" ASPX HOM 2ll/HIM NONE y •0.23 COC.METS 0.24 97,8 0. I OC.'C>C'JO. I 3BZ£l 
168 M E 1233-89 ALC NAT 4!>101M NONE. y NEG LIDOCAINEl(Jl llNINE 
169 ME1246-89 ASl'X SlJIC 17101M NONE y NEG 0.08THIOl~IDA:t.INE 
170 ME1259-89 ASHD NAT 71/W/M roNE y NEG NIA 
. 
(' 
L() 
171 MEl267-89 Al.(' PEND 6WWIF NONE y N/A NI /\ 
172 ME1274-89 DIS NAT 2311)/M I DAY y NEU 11.6 Pl IENYTOIN 
173 ME1298-89 DIS NAT 70/W/M UNKNOWN Y N / /\ NI A 
174 ME1299-89 IN.1 Ac :c 58/W/ M NONE y NIA NIA 
175 ME 13CXl-89 PEND l'l :O: ND 42/W/F NONE y QNS 0.95METI l/\DONH/l .IDOC:/\INE 
176 MEl312-89 ccr PE ND 30/ lllF NONE y N/ A NI A 
177 ME.1313-89 INJ /\CC .~9/W/M <lHR y NI A NIA 
178 MEl314-R9 ASl-ID NAT 64/W/M NONE y N/A NIA 
179 MEl323-89 /\SIID NAT 53/B/M NONE y NEG N/ A 
180 MP.1325-89 ASllD ACC 76/W/M NONP. y N /A 0. 2DIAZI £./0 .2NORD/0.2TF.MA:t.I W AM 
181 ME1327-8<J SIDS l'l\ND I MO/W/ M NONE N N/ A NDD 
182 MP.1328-89 DROWN /\CC 82/WI F NONE y N/ A 2.9 Pl IENC >BARBITAi . 
183 ME1336-89 C."'CI" /\CC 32WK/WI NONE y N/A N/ /\ 
184 MP.1338-89 IN.I /\CC 23/W/M NONE y N/A NI A 
185 MEl343-R9 INJ llC>M 211/WIM NONE y N/ A N/ A 
186 MEl36S-89 sc;w SUIC 80/W/M NONE y NHG NDD 
187 ME1370-89 DIS NAT 71'./W/F 21 DAYS y N/ A NI A 
188 ME1380-89 DIS NAT 4:J/W/M NONE y N/ A 15.51'1 JP.NOBARBIT/\1 ./19.51'1 IENYTOIN 
189 MP.1383-89 A'>llD NAT 61./W/M NONE y N/ A N//\ 
190 ME 140.'\-89 INJ /\CC 59/WIM I llR y NEG NDD 
191 MEl409-89 OD UNO ASS 2'J/W/M NONE y N/A 0.Sl'RO/O. 7Nl'N0. I2FIU!f ~MOR/0. 41 TC >T 
192 ME1411 -89 OD UNCIASS 31/W/M NONE y N/A 0.23FRl.!EMOR/ l .36TOTMOR 
193 MP.1413-89 DROWN /\CC 2<o!WIM NONE y N/ A NI A 
194 ME1415-89 OD SIJIC 39/W!f' 3HRS y N/A C>. 7!.llM IPl~/\M INE/9.K'\l)ESIPR/\M INJ ; 
195 MEl426-8<J DIS NAT 34/W/F 41 ll~S y B/\IU\S 8.0 l'l IENOllARBITAI . 
196 MEl 440-89" OD lJNCI ASS 29/W/M < 11-IR y ~o. 41 COC.METS 1.07D7H 0.08CCX1 1.42BZE 
197 ME1442-89 GSW SUIC 18/W/ M <IHR y N/ A N/A 
198 ME1461 -R9 OD llNCIASS 42/W/F NONE y NI A 0.76TOTMORl'l llNH 
199 MEl463-89 ASllD NAT 33/W/F I llR y N/A NDD 
200 MF.1464-89 ALC NAT 71/B/M IOllRS y Nl\O NDD 
• 
. co 
· I.{) 
201 
202 
203 
ME1473-89 SIDS 
ME1491-89 ccr 
MB1497-89" ) PBND . 
204 ME150S-89 
205 MEl 5CJ6..89 
206 ME1507-89 
ASPX 
SIDS 
GSW 
207 
208 
209 
210 
211 
212 
213 
214 
215 
216 
217 
ME1508-89 GSW 
ME1511-89 ALC 
ME1512-89" . GSW .• 
MB1513-89 PEND 
:t.IBi$~ i: ;:: o~w 
MB1S47-89 GSW 
ME.1543-89 OD 
ME1555-89 CV A 
ME1S57-S!r .. : A~BU 
ME1567-89 INJ 
ME1571-89"' CCf 
218 ME1572-89 
219 MEl600-89 
220 MEl605-89 
221 MB1609-89 
222 MEl613-89 
223 ME1616-89 
224 ME1626-R9 
225 ME1633-R9 
226 ME1648-89 
227 ME1650-89 
228 MBl 653-89"' 
229 ME.1665-89'" 
230 MEl 6<'6-89 
INJ 
GSW 
GSW 
PEND 
INJ 
INJ 
ASHD 
IN.I 
INJ 
ASPX 
00 
PEND 
INJ 
PEND 
ACX:: 
PBNt> 
ACC 
PENO 
HOM 
2.5MO/WI NONE N NIA 
20/WIM >4-5 DAYS N NIA 
6WKJV'/M NONE ... \' • : : •o.oi qoc~rs· 
57/W/M NONE 
2MO/W/M NONE 
49/WIF NONE 
SUIC 47/W/M 
y 
y 
y 
y 
NIA 
QNS 
NIA 
NEG 
UNCLASS 34/W/M Y NIA 
.: ONS ::· 
NDD 
NIA 
0.08COC/NB<JBZE 
0.3NORTRU"fYLINE 
QNS 
NIA 
NDD 
NIA 
HOM. . '1,1/W{M :: 
NONE 
NONE 
NO.N~ . . . . . . O. l5C;OC/0,4513ZE ~w~za ~,.:: .;. ::: •o.:l~ ~t.iia+s ·· 
ACC 16/W/M 
... ~q~ ··: n~ 
HOM 22/W/M 
UNCl.ASS 14/W/F 
NAT 59/W/F 
Nl\T .. 29tWM 
ACC 3/WIM 
ACX.: 25/W/M 
ACC 
SlJIC 
SUIC 
PEND 
MVA 
ACC 
NAT 
MVA 
ACC 
SUIC 
SlJIC 
PEND 
MVA 
18/W/F 
53/WIM 
32/WIM 
71/WIF 
86/WIF 
31/WIM 
52/W/M 
72/W/M 
22/W/M 
17/WIM 
40/B/F 
42/W/M 
24/WIF 
3 DAYS Y N/A QNS 
· 9-s·H~Y/'. · X::i:. ::: ~i:zij ~~sti-$:· ;:.· i: z. 11 ~ · •. ••• O.~o:m~e; 
NONE 
NONE 
y 
y 
NEG 
NIA 
NONE Y NEG 
<f Fili :::. ·~ :;:: ·: o:oo :c0c::~a:t~. t :' ' o.oi e;ui .·· 
NONE 
NONE 
5DAYS 
NONE 
NONE 
<1 llR 
MINS 
<1 llR 
NONE 
NONE 
MINS 
MINS 
NONB 
NONB 
2.5 HRS 
y 
y 
y 
NEG 
•0.03 COCME'C'S 
NIA 
Y NIA 
Y NIA 
Y BARl1S 
Y NEG 
Y NIA 
Y NEG 
Y NIA 
Y NIA 
Y NEG 
Y "0.tOCOC.METS 
Y . "0.0l C:OCMET'S 
y NIA 
0.49BZE 
0.21 OZB 
o.ooaze 
NOD 
1.7AMITRIPTYLINE/2.2NORTRJP. 
NDD 
.O.Q9-J'Oi'MOR./0.02FR,BBCo0/0.24'J'OT. ·· 
NIA 
NEGCOC/O.lrTBZf:! 
0.0301AZEPAMl <O.OINORDIA:l.EPAM 
NIA 
NIA 
13.0 MCGIMI , Pl IHNO 
DEXl'ROMETI IORPI JAN 
NIA 
<2.5 MCG/ML Pl IENYTOIN 
NIA 
NOD 
l.IDOC'AINE 
NEG CX>C'./0.14 OZE/0.71PROP 
NIA 
NIA 
. 
. °' I.I) 
231 MEIU>il-ll9 GSW SUIC 41/W/M NONE y N/ A N/ A 
232 M E 1671 -89 ASllD NAT 57/WIM NONE y NIA NIA 
233 ME1676-R?" INJ llOM 26/WIF NONE y •o.24 C:OCMETS 0.31 BZH 0.62C:OC/0. 768i".E 
234 MEl6R7-R9 DIS NAT 67/WIM NONE y NEG < 2.5 MCGIML l'l IHNYTOIN 
235 MEl692-1<9 IN.I llOM 53/WIM NONE y NIA 9.3MCGIML Pl IENO 
236 ME1696-R9 ANEll NAT 371WIM NONE y NIA NIA 
237 ME1697-/l'J INJ ACX' 5R/WIM NONE y NEG 0.2DIN0.3NOR/.38FI .X/.03NORl'l .X 
238 ME17Hl~89 IN.I A<X: 2/WIF NONE y NIA NIA 
239 ME1713-8') OD ACC 26/Wtr NONE y NIA t .SPR0/1.1 NP N.37CYCT ,ClBEN7 .. 
240 ME1714-89 INJ l-IOM 3 .~IB/F NONE y NIA 14.8PllHNO 
241 MEHJ9-89 INJ ACX.: 41/W/M NONE y NIA NIA 
242 MP.1741 -89 IN.I MVA 34/WIM I llR y Nl'.G I .IJ)OCAINE 
243 M E 1743-8<> CCI' MVA 21/WIM 30 llRS y NIA NDO 
244 MEl745-89 ASPX SUlC 16/WIM NONE y NEO NDD 
245 ME1753-8? INJ MVA 21/WIM NONE y NIA NIA 
246 MEl754-89 ASllD NAT 45/WIM NONE y NIA NIA 
247 M E l780-89 Al .C NAT 56/WIM MONE y NIA NIA 
248 ME1801 -89 osw llOM 58/W/M 1 llR y NIA NIA 
249 MEIR! 1-8',. INJ MVA 3!.l/W/M NONE y •o.ss C:OC.METS 0.41 nze 0.42B7E/Nf·:G CO<.: 
250 ME1812-89- INJ MVA 29/WIP NONE y •0.33 COC:.MBTS o.57 nze 0.25137.E 
251 MEIRZ2-89 PEND I' fl ND IM/BIM NONE y NIA QNS 
252 ME18Z.~-89 DIS NAT 49/WIM 8Hl{S y NIA NIA 
253 MEl826-/!9 C< :T MVA 16/WIF NONE y NIA NIA 
254 MEIR2<J-R9 (.."'() ACC 36/WIM NONE y NIA NIA 
255 MHIK34-89 DIS NAT 47/W/M 1 llR y NEG U.16Fl.XIO. t 4NFX/0.2DIA 
256 ME11<38-8<r 00 UNCL 33/WIM NONE y • 1.os C.'OC.METS t .oz ll2'.E 3. 99COC/2. l 9137.E 
257 MEIR3'J-89 INJ MVA 31/WIM 1 llR y NIA NOLJ 
258 ME1841 -89 GSW llOM 62/WIP NONE N NIA 0.6NORDIAZHPAM 
259 ME185S-R<r ASPX SUlC 42/HIM NONE y •1.01 COC.METS 0.58UZB O.O!'C .. :OC/O. 53BZB 
260 MEl856-R9 GSW llOM 35/l)IM 1.5 HRS y NEG L.IOOCAINE 
. 
0 
I.::> 
261 
262 
263 
264 
265 
266 
267 
268 
269 
270 
271 
272 
273 
274 
275 
276 
277 
278 
279 
280 
281 
283 
284 
285 
286 
287 
288 
289 
JUNE1989 
ME1864-89 
M81899-3'.r 
. ME1901~ . 
ME1905-89 
ME1908-89 
MEl935-89" : 
ME1943-89 
ME1952-89 
ME1953-89 
MB.1970-89 
ME198l-89 
ME1985-89 
: Mli.si!n-89o. 
ME199S-89 
ME2002-89 
ME2162-89 
ME2164-89 
ME2166-89 
MB2171 -89 
MB2193-89 
ME2215-89 
ME:ZOCl3-89 
M82005-S•r 
MEZO<l9-1!9'" 
ME2006-89 
ME2014-89 
ME2023-89 
ME2027-89'" 
290 ME2039-119 
Bl.EC 
osw 
." lVDA 
ASHD 
cx.-r 
)NJ 
CCT 
CCT 
ASHD 
!NJ 
DJS 
ASHD 
cx:r 
DIS 
PEND 
INJ 
ASHD 
DIS 
ASPX 
ccr 
IN.l 
SUDS 
OD 
osw 
INJ 
OD 
ASHD 
ASPX 
ASJID 
ACC 
HOM 
tJNq..A 
NAT 
ACC 
SUJC 
HOM 
ACC 
NAT 
ACC 
NAT 
NAT 
3WW/M NONE 
3:l/H/M J .$HRS 
27/W/M N9N~ 
36/W/M MINS 
48/W/M NONE 
2S/W/M MINS 
4S/WIM NONE 
66/W/M l WK. 
41/W/M NONE 
34/W/M NONE 
2/W/M NONE 
64/W/M NONE 
MVA ,;° 3<V91P,;'(. N~B 
NAT 21/W/M NONE 
PEND 9G'W/M 6 IJRS 
MVA 24/W/M NONE 
NAT 31/W/M MINS 
NAT 63/W/M I HR. 
SUJC 25/B/M NONE 
/\CC 81/W/F 9 DAYS 
AC.:C 7S/W/M 2S DAYS 
PE ND 50/W/M NONE 
UNO.ASS 
SUIC 
ACC 
ASPX 
NAT 
SUIC 
NAT 
31/W/F NONE 
21/W/M NONE 
21/W/M NONE 
37/W/M NONE 
60/WIM NONE 
28/WIM NONE 
72/W/f' NONE 
Y N/A 
Y .' •o.s2coCMBTS 
Y ' _'-z.59 COCMSTS 
Y NIA 
Y N/A 
y ' •1.38CO<;.MB'.J"S ' 
Y NIA 
Y N/A 
Y NIA 
Y NIA 
Y N/A 
Y N/A 
*9-5l ~~Ts:· 
Y BARBS 
Y NIA 
Y NIA 
Y N / A 
Y NEG 
Y NIA 
Y NEG 
Y NEG 
Y NIA 
Y •0.9<JCOC.MIJTS 
Y •0.50 C:OCMBTs 
Y NIA 
N NIA 
Y NIA 
Y •o.08 C.:OCMB'l'S 
y NIA 
0. ... 1 ozti. 
o.!lOB~ 
P,83 OZB 
:: 0.6Ssm 
1.23 BZB 
0.17137.E 
0.1)3 BZB 
NIA 
0 .22C000.47BZR 
O.l \QOPO. 77BZE 
NIA 
N/A 
0. l6CQC/0.112BZB 
NIA 
NIA 
N/A 
NIA 
NIA 
N/A 
<i.1'1Cot-.1~ 1m;z.e 
NDD 
23.0 'IHEOPHYLLINE 
:.•.·:· 
NIA 
O.<Y7FRl ~EMO£VO.CJ'.ll'O'l'.MOR 
NDD 
NDD 
NDD 
NIA 
NIA 
l4.75COC./4.S2llZE 
NHOCOC.:tNEGB7.E 
NI A 
N/ A 
NIA 
0.21COC.'./0.33BZE 
NIA 
. 
rl 
\.0 
291 M1- ~20.i;;z X'> t;sw llOM IWWI F NONE N NI I\ NI'.< iCOC'/I I hi Ii'!! 
292 ME204X X'I SIDS l'END 6WKl ()I F NONE N N / /\ NDI) 
293 Ml '20<;6-X'I ))ROW /\CC <12/IVM NC>NE y Ni;<; NDD 
294 MF.20<;7-l«J C(T /\( :c 90/ W/F 4 llRS y N II\ NDD 
295 ME20<12-X'J /\SI ID N/\T 'l,2/ W / P llOIJl{S y N / /\ Nl)IJ 
296 ME2072 X9 /\SI II) N/\T 741W / M NONE y N //\ N/ /\ 
297 MP.21174-X9 l)HOW /\CC: H/W/M NONE y NII\ N / i\ 
298 M K20X7 -X'J CCT /\C:C FT/W/ M NClNE y NI I\ NI A 
299 ME21I1 - .'~<J ()() /\CC. 3<;/ W / M NONE y N / /\ 2. 3l '/\ R II/\ M /\:I.I '.I' IN 1, 
300 ME2 1<~J X') DIS NAT 43/11/ F NONE y NI I\ NI I\ 
301 Mll21 21 ·X'I OD /\( :c '.IX/ Wfl' NONE y N/ A l..'iOPIO!I" '01)1 '.INl .;/1 .77TOTC 'C >11. 
302 ME2 117 X'J l'l!ND PEND :"4/W/M NONI! y Nii\ O.<><IMEl'Fl{IUIN!Cf l .II) 
303 Ml ;212C>-X9 ()l{OW /\('(' 3XI WI M NONE y N //\ NII\ 
304 MF.2132-x9 ()ROW /\C'C 62/ll/ M NONE N N/ /\ NI A 
305 Ml'.2 136-X'I ccr MV/\ '.12/W I M NONE y Nl!li NDO 
306 Ml ~2 153- X9 ()I) /\( :c . 5'>,I W I F NONE y N t i\ x.111ox1;i•1N 
307 MIC21.S(• IN GSW SllJC •Kl/ W / M 6 U/\ YS N N/ A Ni i\ 
ACC 
ALC 
ANEU 
ASHD 
ASPX 
ASTM 
CCT 
COI 
COPD 
DIS 
DMVA 
DROW 
ELECT 
EXSG 
GSW 
HGSW 
HOM 
IDDM 
IVDA 
LIV 
MVA 
NAT 
OD 
PEND 
RHD 
SGSW 
SIDS 
SUDS 
sure 
SURG 
APPENDIX B. 
CAUSE OF DEATH MASTER LIST 
ACCIDENTAL 
ALCOHOLISM (ACUTE/CHRONIC) 
ANEURYSM 
ARTERIOSCLEROTIC HEART DISEASE 
ASPHYXIA 
ASTHMA 
CRANIO-CEREBRAL TRAUMA 
CARBON MONOXIDE INTOXICATION 
CHRONIC OCCLUDED PULMONARY DISEASE 
DISEASE 
DRIVER/MOTOR VEHICLE ACCIDENT 
DROWNING 
ELECTROCUTION 
EXSANGUINATION 
GUN SHOT WOUND 
HOMICIDE GUN SHOT WOUND 
HOMICIDE 
INSULIN DEPENDENT DIABETES MELLITUS 
INTRAVENOUS DRUG ABUSE 
LIVER NECROSIS 
MOTOR VEHICLE ACCIDENT 
NATURAL DEATH 
OVERDOSE 
PENDING 
RHEUMATIC HEART DISEASE 
SUICIDE/GUN SHOT WOUND 
SUDDEN INFANT DEATH SYNDROME 
SUDDEN UNEXPLAINED DEATH SYNDROME 
SUICIDE 
SURGICAL MISADVENTURE 
62. 
>>>>AUTOTUNE REPORT<<<< 
DATE 
SYSTEH#2 
TUNE TYPE 
5/21/91 lli20 
5970( TOX-II ) 
Tuned from previous values 
SERIAL NO.: 2716Al0l33 
EI MODE; POSITIVE 
Repller IonFcs EMvlts Gain Offset EntLens X-ray Maas 
Volts Volta Volta DA Ca DACa mV/AMU Volta Gain 
Initial: 10.2 0 2693 166 82 65 108 122 
Final: 10.2 0 2835 166 82 60 120 122 
Mass Abs.Abund Rel.Abund Trgt.Abund Iao.Maaa Iao.Abund. I so.Ratio 
69.00 131141 100.00\ 100.00\ 70.02 1421 1.08\ 
218.95 104416 79.62\ 35.00\ 219.95 4608 4.41\ 
502.00 9546 7.28\ 2.00\ 503.00 991 10.39\ 
Autotune finished 
rull Spectrua X1 
4 
2 
288 II 8 6 8 7 0 • • 
Abs. Rel. ~~u~ Iso. Iso. Iso. ~:u~ nass Abund Rallo nass Abund Ratio 
69.88 1211168 189.89% 188.88% 78.89 1364 1.89% 1.88% 
218.911 96584 77.17% 3!!.88% 219.9!! 4'51 4.81!%. 4.32% 
!582.89 7832 6.26% 2.eex 583.18 746 '.ux 11.11x 
APPENDIX C. 
63. 
Mass 
Offset 
15. 
15 
Tr9t.Ratio 
1.08\. 
4.32\ 
10.11\ 
APPENDIX D. 
COCAINE/BENZOYLECGONINE PROCEDURE1 
1) ADD TO A CLEAN TEST TUBE: 
INTERNAL STANDARD (500 NG DJ-COCAINE) 
(500 NG DJ-BENZOYLECGONINE) 
1 ML OF SPECIMEN (BLOOD,URINE,GASTRIC,ETC) 
2 ML PHOSPHATE BUFFER PH 7.0 
64. 
2) MIX AND ADD TO EXTRELUT EXTRACTION COLUMN. LET ADSORB 4-5 
MINS 
J) ELUTE INTO A DISPOSABLE 15 ML CENTRIFUGE TUBE WITH TWO 8 
ML ALIQUOTS OF 9:1 CHCLy/ISOP 
4) SPLIT SAMPLE AND EVAPORATE TO DRYNESS ON N-EVAP 
5) DERIVATIZE BENZOYLECGONINE IN ONE TUBE TO N-PROPYL COCAINE 
BY BOILING OVER AN OPEN FLAME WITH N,N DIMETHYLFORMAMIDE 
DI-N-PROPYL ACETAL FOR JO SECONDS 
6) ADD lML H2S04 TO TUBE. 
7) CLEANUP STEP. ADD J ML OF TOLUENE:HEPTANE:ISOAMYL ALCOHOL 
(76:20:4) TO AQUEOUS AND VORTEX DISCARD ORGANIC. 
8) NEUTRALIZE AQUEOUS WITH 2 ML SODIUM CARBONATE BUFFER PH 
9.0 
9) EXTRACT WITH J ML OF TOLUENE:HEPTANE:ISOAMYL ALCOHOL. 
TRANSFER ORGANIC PHASE TO A CLEAN CONICAL CENTRIFUGE TUBE 
AND EVAPORATE ON N-EVAP. 
10) RECONSTITUTE WITH 100 UL CHCL;s AND TRANSFER TO AN 
AUTOSAMPLER VIAL FOR MASS SPECTRAL ANALYSIS. 
MASS SPECTROMETER PARAMETERS 
METHOD- COCBEN::D5 
INJECTION VOLUME- Jul 
IDFILE- IDBEC 
FMGR TR FILE- SIMFX::D5 
1 ADAPTED FROM "A METHOD FOR THE SIMULTANEOUS 
DETERMINATION OF COCAINE, BENZOYLECGONINE AND 
ECGONINE METHYL ESTER IN BLOOD AND URINE USING 
GC/EIMS WITH DERIVATIZATION TO PRODUCE HIGH MASS 
MOLECULAR IONS" ISENSCHMID ET AL.,JOUR. OF ANAL. 
TOX.12:9-10;1988 
APPENDIX E. 
Correlation Coefficient: 
where sxy = 2< x - X) (y - y) 
=2_cx - -X-) 2 , sYY 
65 . 
The quantities Sxx and SYY are the sums of squared deviations 
of the x observations, and the y observations, respectively, 
sxy is the sum of cross products of the x deviations and the 
y deviations. 
N.B.: An observed correlation between two variables may be 
spurious. That is, it may be caused by the influence of a 
third variable. 
Standard Deviation: 
s 
= ~x_2 ___ 1_;_n_«.2_x_) _2_ 
n - 1 
Coefficient of Variation: 
s 
CV % = 
66. 
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